An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
Clinical trial NCT07583953 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07583953
- Sponsor
- Suzhou Abogen Biosciences Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-17
- Primary completion
- 2029-01-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.